Acta Scientific Neurology (ASNE) (ISSN: 2582-1121)

Literature Review Volume 6 Issue 8

Correlation Between the Fasting Blood Glucose Level and the Severity of Clinical Manifestation of Peripheral Neuropathy on Diabetic Patient

Santoso Jaeri*

Department of Medical Biology and Biochemistry, Faculty of Medicine, Universitas Diponegoro Semarang, Indonesia

*Corresponding Author: Mario Carvi Nievas, Department of Medical Biology and Biochemistry, Faculty of Medicine, Universitas Diponegoro Semarang, Indonesia.

Received: June 13, 2023; Published: July 25, 2023

Reprints View PDF Related Articles

Abstract

Background: The prevalence of Diabetes Mellitus (DM) in 2017 was 8.8% and is predicted to increase to 9.9%. Diabetic peripheral neuropathy is one of the common complications occurred in people with DM. There is controversy regarding the correlation of the fasting blood glucose level with the severity of its manifestation.

Aim: To identify the correlation between the fasting blood glucose level and the severity of peripheral neuropathy on diabetic patient.

Methods: An analytic observational study using cross-sectional design from sixty-one patients with type 2 diabetes. The severity of peripheral neuropathy clinical manifestation measured using Modified Toronto Clinical Neuropathy Score. The fasting blood glucose levels measured from the intravenous blood after fasting for 8 hours. Data analyzed using statistic software SPSS 26. Bivariate correlation test analyzed using spearman correlation coefficient.

Results: There is no correlation correlation between the fasting blood glucose level and severity of peripheral neuropathy on diabetic patient (p = 0.875, r = -0.22).

Conclusion: The fasting blood glucose level does not correlate with the severity of peripheral neuropathy on diabetic patients

Keywords: Diabetes Mellitus; Fasting Blood Glucose; Modified Toronto Clinical Neuropathy Score; Peripheral Neuropathy

References

  1. World Health Organization. Diabetes (2020).
  2. Sarwar N., et al. “Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Emerging Risk Factors Collaboration”. Lancet9733 (2010): 2215-2222.
  3. Bourne RR., et al. “Causes of vision loss worldwide, 1990-2010: a systematic analysis”. Lancet Global Health6 (2013): e339-e349.
  4. United States Renal Data System. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases”. American Journal of Kidney Diseases (2014). USRDS annual data report: Epidemiology of kidney disease in the United States (2015): 188-210.
  5. Khawaja N., et al. “The prevalence and risk factors of peripheral neuropathy among patients with type 2 diabetes mellitus; the case of Jordan”. Diabetology and Metabolic Syndrome 8 (2018): 1–10.
  6. Kurniawan SN. “Patofisiologi Biomolekular Neuropati Diabetes”. Maj Kedokt Neuro4 (2012): 66–75.
  7. Standards Of Medical Care in Diabetes-2019. Riddle MC, editor. USA: American Diabetes Association (2019).
  8. IDF Diabetes Atlas 8th edition. Karuranga S, Fernandes J da R, Huang Y, Malanda B, editors”. International Diabetes Federation (2017): 3-145.
  9. Levterova B., et al. “Prevalence, and Impact of Peripheral Neuropathy on Quality of Life in Patients with Diabetes Mellitus Pilot Study”. Trakia Journal of Sciences1 (2018): 71–76.
  10. Oh SJ. “Clinical electromyography: nerve conduction studies. In: Nerve conduction in polyneuropathies”. Baltimore: Williams and Wilkins (2012): 579–591.
  11. Bansal V., et al. “Diabetic neuropathy”. Postgraduate Medical Journal 964 (2011): 95–100.
  12. World Health Organization. Diabetes (2020).
  13. Deshpande AD., et al. “Epidemiology of diabetes and diabetes-related complications”. Physical Therapy 11 (2008): 1254-1264.
  14. Holzer SE., et al. “Costs, and duration of care for lower extremity ulcers in patients with diabetes”. Clinical Therapeutics1 (1998): 169-181.
  15. Caputo GM., et al. “Assessment and management of foot disease in patients with diabetes”. The New England Journal of Medicine 13 (1994): 854-860.
  16. Mouri M and Badireddy M. “Hyperglycemia”. StatPearls Publishing (2020): 1-7.
  17. Liu X., et al. “The risk factors for diabetic peripheral neuropathy: A meta-analysis”. PLoS One2 (2019): e0212574.
  18. Azmiardi A., et al. “Factors Associated with Diabetic Peripheral Neuropathy among Patients with Type 2 Diabetes Mellitus in Surakarta, Central Java”. Indonesian Journal of Medicine4 (2019): 300-312.
  19. Callaghan BC., et al. “Enhanced glucose control for preventing and treating diabetic neuropathy”. Cochrane Database of Systematic Reviews 6 (2012): CD007543.

Citation

Citation: Santoso Jaeri. “Correlation Between the Fasting Blood Glucose Level and the Severity of Clinical Manifestation of Peripheral Neuropathy on Diabetic Patient". Acta Scientific Neurology 6.8 (2023): 41-46.

Copyright

Copyright: © 2023 Santoso Jaeri. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate32%
Acceptance to publication20-30 days

Indexed In




News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is July 10, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US





+91 9182824667

     info@acta-scientific.com

Creative Commons License Open Access by Acta Scientific is licensed under a Creative Commons Attribution 4.0 International License
Based on a work at https://actascientific.com

ff

Acta-Publications

ff

© 2021 Acta Scientific, All rights reserved.